OOIR: Observatory of International Research

Papers

(The median citation count of Blood Cells Molecules and Diseases is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Increased expression of CD8 marker on T-cells in COVID-19 patients	109
Leukocyte adhesion to P-selectin and the inhibitory role of Crizanlizumab in sickle cell disease: A standardized microfluidic assessment	35
Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies	30
Direct and indirect effects of the SARS-CoV-2 pandemic on Gaucher Disease patients in Spain: Time to reconsider home-based therapies?	24
Effectiveness of convalescent plasma in Indian patients with COVID-19	24
ABO blood groups, COVID-19 infection and mortality	23
Hematologically important mutations: The autosomal forms of chronic granulomatous disease (third update)	22
Hematologically important mutations: X-linked chronic granulomatous disease (fourth update)	20
Down-regulation of lncRNA NEAT1 regulated by miR-194-5p/DNMT3A facilitates acute myeloid leukemia	20
Splenectomy and the incidence of venous thromboembolism and sepsis in patients with autoimmune hemolytic anemia	18
Circ-PTK2 promotes the proliferation and suppressed the apoptosis of acute myeloid leukemia cells through targeting miR-330-5p/FOXM1 axis	18
Facing COVID-19 in the hematopoietic cell transplant setting: A new challenge for transplantation physicians	16
Is the erythropoietin-erythroferrone-hepcidin axis intact in human neonates?	15
A case of VEXAS syndrome associated with EBV-associated hemophagocytic lymphohistiocytosis	14
Potential causal role of l-glutamine in sickle cell disease painful crises: A Mendelian randomization analysis	14
Sickle cell disease clinical phenotypes in Nigeria: A preliminary analysis of the Sickle Pan Africa Research Consortium Nigeria database	13
BRAF V600E mutation in childhood Langerhans cell histiocytosis correlates with multisystem disease and poor survival	13
EPAS1 regulates proliferation of erythroblasts in chronic mountain sickness	12
MicroRNA expression patterns in HbE/β-thalassemia patients: The passwords to unlock fetal hemoglobin expression in β-hemoglobinopathies	12
Acquired von Willebrand syndrome in ECMO patients: A 3-year cohort study	11
Numbers of long-term hematopoietic stem cells from bone marrow of fanca and fancc knockout mice can be greatly enhanced by their collection and processing in physioxia conditions	10
Czech and Slovak Diamond-Blackfan Anemia (DBA) Registry update: Clinical data and novel causative genetic lesions	10
Lysophosphatidic acid-induced pro-thrombotic phosphatidylserine exposure and ionophore-induced microvesiculation is mediated by the scramblase TMEM16F in erythrocytes	10
Hypoxia induced up-regulation of tissue factor is mediated through extracellular RNA activated Toll-like receptor 3-activated protein 1 signalling	10
Decreased erythrocyte binding of Siglec-9 increases neutrophil activation in sickle cell disease	10

Coagulopathy in cytogenetically and molecularly distinct acute leukemias at diagnosis: Comprehensive study	10
Upregulation of cytokine signalling in platelets increases risk of thrombophilia in severe COVID-19 patients	10
Severe immune thrombocytopenia after COVID-19 vaccination: Report of four cases and review of the literature	9
Benserazide as a potential novel fetal hemoglobin inducer: an observational study in non-carriers of hemoglobin disorders	9
Thrombin generation in plasma of patients with haemophilia A and B with inhibitors: Effects of bypassing agents and antithrombin reduction	9
The IL-33 Receptor/ST2 acts as a positive regulator of functional mouse bone marrow hematopoietic stem and progenitor cells	9
Potential ‘significance’ of monoclonal gammopathy of ‘undetermined significance’ during COVID-19 pandemic	8
Benserazide racemate and enantiomers induce fetal globin gene expression in vivo: Studies to guide clinical development for beta thalassemia and sickle cell disease	8
RNF220 promotes the proliferation of leukaemic cells and reduces the degradation of the Cyclin D1 protein through USP22	8
Daratumumab for pure red cell aplasia post ABO incompatible allogeneic hematopoietic stem cell transplant for aplastic anemia	8
Mitapivat increases ATP and decreases oxidative stress and erythrocyte mitochondria retention in a SCD mouse model	8
Frequency and perturbations of various peripheral blood cell populations before and after eculizumab treatment in paroxysmal nocturnal hemoglobinuria	8
Hematologically important mutations: Leukocyte adhesion deficiency (second update)	8
Clinical and health-related quality of life outcomes of transfusion-dependent thalassaemia patients in Singapore	8
The potential role of emicizumab prophylaxis in severe von Willebrand disease	8
Early initiation of high-dose oral ambroxol in combination with enzyme replacement therapy in a neuropathic Gaucher infant	7
Cross-sectional analysis of adhesion in individuals with sickle cell disease using a standardized whole blood adhesion bioassay to VCAM-1	7
Prognostic factors associated with COVID-19 related severity in sickle cell disease	7
Early iron supplementation and iron sufficiency at one month of age in NICU patients at-risk for iron deficiency	7
Effects of Eupalinilide E and UM171, alone and in combination on cytokine stimulated ex-vivo expansion of human cord blood hematopoietic stem cells	7
Loss of ZNF215 imprinting is associated with poor five-year survival in patients with cytogenetically abnormal-acute myeloid leukemia	7
Performance of serum procalcitonin as a biochemical predictor of death in hematology patients with febrile neutropenia	7
Age of first pain crisis and associated complications in the CASiRe international sickle cell disease cohort	7
Comparison of efficacy and safety of thalidomide vs hydroxyurea in patients with Hb E-β thalassemia - a pilot study from a tertiary care Centre of India	7
A case series highlighting structured hematological, biochemical and molecular approach to clinical oral iron refractoriness in children: A pressing need for a 3-tier system for classification of vari	6
Novel mutations in the bone morphogenetic protein 6 gene in patients with iron overload and non-homozygous genotype for the HFE p.Cys282Tyr mutation	6
Novel mutations in the EPO-R, VHL and EPAS1 genes in the Congenital Erythrocytosis patients	6
Biomarkers and genetic modulators of cerebral vasculopathy in sub-Saharan ancestry children with sickle cell anemia	6
Aberrant expression of cytokines in polycythemia vera correlate with the risk of thrombosis	6
High-throughput methods for the analysis of transcription factors and chromatin modifications: Low input, single cell and spatial genomic technologies	6
Targeted gene expression study using TaqMan low density array to gain insights into venous thrombo-embolism (VTE) pathogenesis at high altitude	6
The association of HBG2, BCL11A, and HBS1L-MYB polymorphisms to thalidomide response in Chinese β-thalassemia patients	6
Global geographic differences in healthcare utilization for sickle cell disease pain crises in the CASiRe cohort	6
Splicing analysis of SLC40A1 missense variations and contribution to hemochromatosis type 4 phenotypes	5
Genetic disruption of KCC cotransporters in a mouse model of thalassemia intermedia	5
A computational study of structural differences of binding of NADP+ and G6P substrates to G6PD Mediterraneanc.563T, G6PD A−c.202A/c.376G, G6PD Cairoc.404C and G6PD Gazac.536A mutations	5
No evidence that chloroquine or hydroxychloroquine induce hemolysis in G6PD deficiency	5
Pediatric bone marrow failure: Clinical, hematological and targeted next generation sequencing data	5
Bone marrow burden score is not useful as a follow-up parameter in stable patients with type 1 Gaucher disease after 5 years of treatment	5
The significance of surface neutrophilic MPO expression level in NETosis and NETosis-associated coagulopathies in covid-19 infected patients	5
Haemoglobin Bristol-Alesha in a child with non-spherocytic severe haemolytic anaemia and marked anisochromic poikilocytosis with basophilic stippling and amorphous intracellular content	4
JAK2V617F mutant endothelial cells promote neoplastic hematopoiesis in a mixed vascular microenvironment	4
Comparison of CRP and procalcitonin for etiological diagnosis of fever during febrile neutropenia in hematology patients- an experience from a tertiary care center in Northern India	4
Heterogeneous phenotype of Hereditary Xerocytosis in association with PIEZO1 variants	4
VCAM1, HMOX1 and NOS3 differential endothelial expression may impact sickle cell anemia vasculopathy	4
TMEM16F mediated phosphatidylserine exposure and microparticle release on erythrocyte contribute to hypercoagulable state in hyperuricemia	4
Sirolimus for treatment of refractory primary warm autoimmune hemolytic anemia in children	4
Good treatment-free survival of monoclonal gammopathy of undetermined significance associated pure red cell aplasia after bortezomib plus dexamethasone	4
Modulation of red blood cell oxygen affinity with a novel allosteric modifier of hemoglobin is additive to the Bohr effect	4
Differential tissue specific expression of Kif23 alternative transcripts in mice with the human mutation causing congenital dyserythropoietic anemia type III	4

Development of a Thalassemia International Prognostic Scoring System (TIPSS)	4
A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients	4
Molecular genetic diagnosis by next-generation sequencing in a cohort of Mexican patients with haemophilia and report of novel variants	4
Novel histone deacetylase inhibitor CT-101 induces γ-globin gene expression in sickle erythroid progenitors with targeted epigenetic effects	4
ANKHD1 is an S phase protein required for histone synthesis and DNA repair in multiple myeloma cells	4
Prognostic significance of CD45 antigen expression in pediatric acute lymphoblastic leukemia	4
Higher AURKA and PLK1 expression are associated with inferior overall survival in patients with myelofibrosis	4
Mutations in RASGRP2 gene identified in patients misdiagnosed as Glanzmann thrombasthenia patients	4
Analysis of baseline characteristics, disease burden and long-term follow-up of 167 patients with Paroxysmal Nocturnal Hemoglobinuria at a single center in Brazil	4
Increased proportion and altered properties of intermediate monocytes in the peripheral blood of patients with lower risk Myelodysplastic Syndrome	3
New germline GATA1 variant in females with anemia and thrombocytopenia	3
Identification and characterization of novel mutations in Chinese patients with congenital fibrinogen disorders	3
Sickle cell disease mice have cerebral oxidative stress and vascular and white matter abnormalities	3
Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR)	3
COVID-19 induces proatherogenic alterations in moderate to severe non-comorbid patients: A single-center observational study	3
Effects of d-ribose on human erythrocytes: Non-enzymatic glycation of hemoglobin, eryptosis, oxidative stress and energy metabolism	3
Platelet-derived microvesicles activate human platelets via intracellular calcium mediated reactive oxygen species release	3
Placental transcriptome profile of women with sickle cell disease reveals differentially expressed genes involved in migration, trophoblast differentiation and inflammation	3
γ′ fibrinogen levels as a biomarker of COVID-19 respiratory disease severity	3
Stathmin 1 deficiency induces erythro-megakaryocytic defects leading to macrocytic anemia and thrombocythemia in Stathmin 1 knock out mice	3
Consequences of parenteral iron-dextran loading investigated in minipigs. A new model of transfusional iron overload	3
Evidence for continued dose escalation of plerixafor for hematopoietic progenitor cell collections in sickle cell disease	3
The effect of transfusion on immune responses in thalassemia	3
Daratumumab as a novel treatment option in refractory ITP	3
Open-label, expanded access study of taliglucerase alfa in patients with Gaucher disease requiring enzyme replacement therapy	3
Identification of TCR repertoires in asymptomatic COVID-19 patients by single-cell T-cell receptor sequencing	3
Manifestation of paroxysmal nocturnal hemoglobinuria after COVID-19 mRNA vaccination	3
Association of mast cells and bone marrow reticulin fibrosis in patients with bcr-abl negative chronic myeloproliferative neoplasms	3
Age-dependent characterization of carotid and cerebral artery geometries in a transgenic mouse model of sickle cell anemia using ultrasound and microcomputed tomography	3
Co-morbidities and mortality in patients with sickle cell disease in England: A 10-year cohort analysis using hospital episodes statistics (HES) data	3
CXCL15/Lungkine has suppressive activity on proliferation and expansion of multi-potential, erythroid, granulocyte and macrophage progenitors in S-phase specific manner	3
KLF1/EKLF expression in acute leukemia is correlated with chromosomal abnormalities	3
Anti-TFPI for hemostasis induction in patients with rare bleeding disorders, an ex vivo thrombin generation (TG) guided pilot study	3
Evidence for complement-mediated bone marrow necrosis in a young adult with sickle cell disease	3
Monoclonal IgM gammopathy in adult acquired pure red cell aplasia: culprit or innocent bystander?	2
Mutation profile of JAK2, EPOR and CALR genes in polycythemia patients	2
Tumor-stroma interaction increases CD147 expression in neoplastic B lymphocytes in chronic lymphocytic leukemia	2
Thirty-five males with severe (Class 1) G6PD deficiency (c.637G>T) in a North American family of European ancestry	2
Pilot assessment of omega-3 fatty acids and potassium thiocyanate in sickle cell anemia patients with conditional peak systolic cerebral artery blood velocity	2
Phenotypic and genetic heterogeneity arising from a novel substitution at amino acid position Val205 in GATA1 related X-linked thrombocytopenia with dyserythropoietic anemia	2
Red cell anarchy. Evidence of neoplastic dyserythropoiesis	2
Dizygotic twins with prolonged jaundice and microcytic, hypochromic, hemolytic anemia with pyropoikilocytosis	2
Misdiagnosis of double heterozygous εGγ(Aγδβ)0-thalassemia/β++ thalassemia as homozygous β-thalassemia: A pitfall for molecular diagnostic laboratories	2
LXRβ is involved in the control of platelet production from megakaryocytes	2
PEST domain NOTCH mutations confer a poor relapse free survival in pediatric T-ALL: Data from a tertiary care centre in India	2
Preclusion of methemoglobinemia caused by nitrate drugs in diabetics and nondiabetics: Possible role of Vitamin C	2
Myeloid-derived suppressor cells anticipate sustained treatment response in newly-diagnosed and persistent primary immune thrombocytopenia	2
Inherited disorders of hemoglobin: A review of old and new diagnostic methods	2
Rapid and automated quantitation of dense red blood cells: A robust biomarker of hydroxyurea treatment response	2
Thrombotic microangiopathy after carfilzomib in a very young myeloma patient	2
Impact of maternal iron deficiency anemia on fetal iron status and placental iron transporters in human pregnancy	2
The association between vitamin D deficiency and hospitalization outcomes in pediatric patients with sickle cell disease	2
Analysis of evolutionary conservation of GPI-anchored proteins between humans and mice	2
Comparative analysis of lentiviral gene transfer approaches designed to promote fetal hemoglobin production for the treatment of β-hemoglobinopathies	2
Hypoferremia of inflammation: Innate host defense against infections	2
Comparative Analysis of the Genetic Variants in Haematopoietic Stem/Progenitor and Mesenchymal Stem Cell Compartments in de novo Myelodysplastic Syndromes	2
Missense mutation in RPS7 causes Diamond-Blackfan anemia via alteration of erythrocyte metabolism, protein translation and induction of ribosomal stress	2
Heptamer-type small guide RNA that can shift macrophages toward the M1 state	2
Rasa3 regulates stage-specific cell cycle progression in murine erythropoiesis	2
Elotuzumab-based maintenance therapy following autologous stem cell transplant in multiple myeloma deepens post-transplant responses	2
Investigating the clinical, hematological and cytogenetic profile of endoreduplicated hypodiploids in BCP-ALL	2
Increased frequency of GNPAT p.D519G in compound HFE p.C282Y/p.H63D heterozygotes with elevated serum ferritin levels	2
Can absolute basophilia distinguish e1a2 BCR-ABL1 chronic myeloid leukemia from chronic myelomonocytic leukemia?	2